NASDAQ / LIVE COMPANY INTELLIGENCE

Greenwich LifeSciences, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERGLSI
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / GLSI COVERAGE

What’s moving Greenwich LifeSciences, Inc. now

Current reporting with the operating signal separated from the noise.

01
Greenwich LifeSciences, Inc.: Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

Greenwich LifeSciences, Inc.: Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

The story matters when it changes Greenwich LifeSciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Greenwich LifeSciences, Inc.: Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

Greenwich LifeSciences, Inc.: Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

The story matters when it changes Greenwich LifeSciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Greenwich LifeSciences, Inc. Provides Update on FLAMINGO-01 Phase III Clinical Trial Safety Data for GLSI-100 Immunotherapy

Greenwich LifeSciences, Inc. Provides Update on FLAMINGO-01 Phase III Clinical Trial Safety Data for GLSI-100 Immunotherapy

The story matters when it changes Greenwich LifeSciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: regulator filings, verified operating scope and liability disclosures.
04
Greenwich LifeSciences, Inc. Updates on GP2 Commercial Manufacturing and Phase III Clinical Trial Progress

Greenwich LifeSciences, Inc. Updates on GP2 Commercial Manufacturing and Phase III Clinical Trial Progress

The story matters when it changes Greenwich LifeSciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest GLSI filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-06-04 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-06-01 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2025-12-18 · Period 2025-12-18SEC ↗8-KMaterial company eventFiled 2025-07-24 · Period 2025-07-19SEC ↗8-KMaterial company eventFiled 2024-12-19 · Period 2024-12-19SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-11-03 · Period 2025-11-03SEC ↗4Official SEC filingFiled 2026-07-30 · Period 2026-07-28SEC ↗
EARNINGS / QUARTERLY TRACKER

Greenwich LifeSciences, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.